Vaginal candidiasis, predisposing factors, symptoms and treatment

Authors

  • Yurimare Radesca Moncayo Facultad de Medicina y Ciencias de la Salud - Universidad Abierta Interamericana Author

DOI:

https://doi.org/10.56294/piii2024347

Keywords:

Vaginal candidiasis, predisposing factors, efficient treatment, women of reproductive age

Abstract

Introduction: Vulvovaginal candidiasis is a disease caused by Candida species, mainly Candida albicans species, which can be colonizing the vaginal microbiota of healthy women, without causing disease. Due to its high prevalence, it is one of the most frequent causes of gynecological consultation. It occurs mainly in women after puberty, worldwide it is estimated that at least 75% of women have had candidiasis at least once in their lives. Its clinical signs are itching, vaginal inflammation and white discharge. It is diagnosed by laboratory tests or culture. A higher frequency of candidiasis occurs in women with high estrogen load or some degree of immunodeficiency. Treatment consists of azole antifungals, particularly fluconazole. The present study consists of a systematic review of the existing literature related to vulvovaginal candidiasis, focusing on epidemiology, clinical signs, diagnosis and treatment. Material and methods: The study design is a literature review for which a search and evaluation of the existing literature and previous research on vaginal candidiasis will be carried out through the databases PubMed, Google Academic, Scielo, Sciendirect, among others. For this purpose, inclusion criteria will be used through searches related to "Candida", "vaginal candidiasis", "recurrent vaginal candidiasis", "vaginal candidiasis predisposing factors" and "candidiasis literature review". Results: Vaginal candidiasis is an infection caused by the overgrowth of Candida albicans, a type of yeast-like fungus that normally lives in the vagina. Predisposing factors include antibiotic use, increased estrogen levels, uncontrolled diabetes, overweight, pregnancy, premenstrual period, taking corticosteroids, and high doses of estrogen. Treatment of vaginal candidiasis includes antifungal medications, such as single-dose oral fluconazole, and avoidance of excess moisture. In uncomplicated vulvovaginal candidiasis, all available forms of antifungals are highly effective, both oral and topical, whereas in complicated vulvovaginal candidiasis, a longer course of 5-7 to 10-14 days of conventional therapy should be performed. Patients who have frequent recurrences require their long-term pressure with oral medications. Conclusion: It is important for health care professionals and patients to be aware of the risks of recurrence so that timely treatment can be provided to patients

References

Cassone A. Vulvovaginal C Andida albicans infections: Pathogenesis, immunity and vaccine prospects. BJOG: An International Journal of Obstetrics and Gynaecology [Internet]. 23 de julio de 2014;122(6):785-94. Disponible en: https://doi.org/10.1111/14710528.12994

Sobel JD. Vulvovaginal candidosis. The Lancet [Internet]. 1 de junio de 2007;369(9577):1961-71. Disponible en: https://doi.org/10.1016/s0140-6736(07)60917-9

Sobel JD. Recurrent vulvovaginal candidiasis. American Journal of Obstetrics and Gynecology [Internet]. 1 de enero de 2016;214(1):15-21. Disponible en: https://doi.org/10.1016/j.ajog.2015.06.067

Foxman B, Muraglia R, Dietz JP, Sobel JD, Wagner R. Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States. Journal of Lower Genital Tract Disease [Internet]. 1 de julio de 2013;17(3):340-5. Disponible en:

https://doi.org/10.1097/lgt.0b013e318273e8cf

Achkar JM, Fries BC. Candida infections of the genitourinary tract. Clinical Microbiology Reviews [Internet]. 1 de abril de 2010;23(2):253-73. Disponible en: https://doi.org/10.1128/cmr.00076-09

Sobel JD, Sobel R. Current treatment options for vulvovaginal candidiasis caused by azole-resistant candida species. Expert Opinion on Pharmacotherapy [Internet]. 13 de junio de 2018;19(9):971-7. Disponible en: https://doi.org/10.1080/14656566.2018.1476490

Denning DW, Kneale M, Sobel JD, Rautemaa‐Richardson R. Global Burden of Recurrent Vulvovaginal Candidiasis: A

Systematic Review. Lancet Infectious Diseases [Internet]. 1 de noviembre de 2018;18(11):e339-47. Disponible en: https://doi.org/10.1016/s1473-3099(18)30103-8

Rosati D, Bruno M, Jaeger M, Oever JT, Netea MG. Recurrent vulvovaginal candidiasis: An Immunological perspective. Microorganisms [Internet]. 21 de enero de 2020;8(2):144. Disponible en: https://doi.org/10.3390/microorganisms802014 4

Pineda-Murillo J. Candidosis vaginal: revisión de la literatura y situación de México y otros países latinoamericanos [Internet]. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_ arttext&pid=S0122-06672017000100009&lng= en.

Sánchez-Martín MA. Importancia clínica de la candidiasis con especial relevancia en la candidiasis vulvovaginal recurrente [Internet]. Sánchez-Martín | Gaceta Médica de Bilbao.2019. Disponible en: https://www.gacetamedicabilbao.eus/index.php/gacetamedicabilbao/article/view/706

Pérez P. Candidiasis vaginal en mujeres embarazadas adultas jovenes [Tesis de Pregrado]. Universidad Católica de Cuenca; 2019.

Ciudad-Reynaud. Infecciones vaginales por Candida: diagnóstico y tratamiento. Revista Peruana de Ginecología y Obstetricia [Internet]. 2007;53:159-66. Disponible en: https://sisbib.unmsm.edu.pe/bvrevistas/ginecol ogia/vol53_n3/pdf/a04v53n3.pdf

Aroca JJ, Martínez PR, Molina L, González AM, García-Arata I, Menchero SP. Epidemiology and Etiology of vulvovaginal candidiasis in Spanish and immigrants’ women in Fuenlabrada (Madrid). Revista espanolã de quimioterapia : publicacioń oficial de la Sociedad Espanolã de Quimioterapia [Internet]. 17 de abril de 2020;33(3):187-92. Disponible en: https://doi.org/10.37201/req/099.2019

Sobel, Mitchell. Candida vulvovaginitis: clinical manifestations and diagnosis [Internet]. MediLib. 2023. Disponible en:

https://medilib.ir/uptodate/show/5452

Farr A, Effendy I, Tirri BF, Hof H, Mayser P, Petricevic L, et al. Guideline: Vulvovaginal candidosis (AWMF 015/072, Level S2K). Mycoses [Internet]. 27 de febrero de 2021;64(6):583-602. Disponible en: https://doi.org/10.1111/myc.13248

Balakrishnan SN, Yamang H, Lorenz M, Chew SY, Than LTL. Role of vaginal mucosa, host immunity and microbiota in vulvovaginal candidiasis. Pathogens [Internet]. 25 de mayo de 2022;11(6):618. Disponible en: https://doi.org/10.3390/pathogens11060618

Rodríguez-Cerdeira C, Carnero-Gregorio M, Molares-Vila A, López-Bárcenas A, Fabbrocini G, Bardhi B, et al. Biofilms and vulvovaginal candidiasis. Colloids and Surfaces B: Biointerfaces [Internet]. 1 de febrero de 2019;174:110-25. Disponible en: https://doi.org/10.1016/j.colsurfb.2018.11.011

Blostein F, Levin-Sparenberg E, Wagner R, Foxman B. Recurrent vulvovaginal candidiasis. Annals of Epidemiology [Internet]. 1 de septiembre de 2017;27(9):575-582.e3. Disponible en :https://doi.org/10.1016/j.annepidem.2017.08.010

Lines A, Vardi-Flynn I, Searle C. Recurrent vulvovaginal candidiasis. BMJ [Internet]. 8 de junio de 2020;m1995. Disponible en: https://doi.org/10.1136/bmj.m1995

Paladine, Desai. Vaginitis: Diagnosis and treatment. American family physician [Internet]. 1 de marzo de 2018;97(5):321-9. Disponible en:https://pubmed.ncbi.nlm.nih.gov/29671516/

Satora M, Grunwald A, Zaremba B, Frankowska K, Żak K, Tarkowski R, et al. Treatment of Vulvovaginal Candidiasis—An overview of guidelines and the latest treatment methods. Journal of Clinical Medicine [Internet]. 18 de agosto de 2023;12(16):5376. Disponible en: https://doi.org/10.3390/jcm12165376

Lírio J, Giraldo PC, Amaral RLGD, Sarmento ACA, Costa APF, Gonçalves AK. Antifungal (oral and vaginal) therapy for recurrent vulvovaginal candidiasis: A Systematic Review protocol. BMJ Open [Internet]. 1 de mayo de 2019; 9(5):e027489. Disponible en: https://doi.org/10.1136/bmjopen-2018-027489

Downloads

Published

2024-06-12

How to Cite

1.
Radesca Moncayo Y. Vaginal candidiasis, predisposing factors, symptoms and treatment. SCT Proceedings in Interdisciplinary Insights and Innovations [Internet]. 2024 Jun. 12 [cited 2024 Oct. 12];2:347. Available from: https://proceedings.ageditor.ar/index.php/piii/article/view/312